COMMUNIQUÉS West-GlobeNewswire

Profusa to Present US-Study Clinical Data at Leipzig Interventional Course (LINC) 2026
11/12/2025
Study conducted at US sites evaluates Lumee TM in peripheral artery disease (PAD) patients BERKELEY, Calif, Dec. 11, 2025 (GLOBE NEWSWIRE) -- Profusa, Inc. (“Profusa” or the “Company”) (Nasdaq: PFSA), a commercial stage [...]
HeartSciences Announces Major Upgrade to User Features of MyoVista Insights Platform with Commercial Launch Version 1.1
11/12/2025
Version 1.1 Designed to Provide Best Usability of any ECG System Southlake, TX, Dec. 11, 2025 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), a healthcare information [...]
2025 Holiday Gift Guide: Bob and Brad Announce Up to 42% Off Best-Selling Wellness Devices
11/12/2025
WINONA, Minn., Dec. 11, 2025 (GLOBE NEWSWIRE) -- Bob and Brad, the physical therapist-founded wellness brand trusted by over 5 million people worldwide, today announced its exclusive Holiday Gift Week Deals . Available [...]
ProteoNic 2G UNic® Technology Licensed by Ginkgo Bioworks for BARDA-Supported Consortium Advancing Monoclonal Antibody Manufacturing for Anti-Filovirus Therapies
11/12/2025
Leiden, The Netherlands – 11 December 2025 – ProteoNic BV , a leading provider of premium vector technology for biopharmaceutical and viral vector production, today announced that its proprietary 2G UNic® technology has [...]
MAIA Biotechnology Announces First Patient Dosed in THIO-104 Phase 3 Pivotal Trial Evaluating Ateganosine as Third-Line Treatment for Advanced Non-Small Cell Lung Cancer
11/12/2025
Key milestone achieved as Company advances clinical program to full approval trial of ateganosine sequenced with a checkpoint inhibitor in comparison to chemotherapy CHICAGO, Dec. 11, 2025 (GLOBE NEWSWIRE) -- MAIA [...]
Inotiv Partners with VUGENE to Advance AI-Driven Drug Discovery and Bioinformatics Capabilities
11/12/2025
WEST LAFAYETTE, Ind., Dec. 11, 2025 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, or “Inotiv”), a leading Contract Research Organization (CRO) specializing in nonclinical and analytical drug discovery [...]
Nephros Launches the Nephros Water Institute to Lead National Water Safety Education
11/12/2025
New initiative accelerates cross-industry engagement, expands educational reach to drive long-term growth in water quality solutions SOUTH ORANGE, N.J., Dec. 11, 2025 (GLOBE NEWSWIRE) -- Nephros, Inc. (Nasdaq: NEPH), a [...]
Williamsburg Therapy Group Joins the Lumina Therapy Alliance, Strengthening the Nation’s Premier Network of High-End In-Person Mental Health Practices
11/12/2025
NEW YORK, Dec. 11, 2025 (GLOBE NEWSWIRE) -- Lumina Therapy Alliance , the country’s first and only curated collective of elite, out-of-network in-person mental health practices, is proud to announce that Williamsburg [...]
GRI Bio Announces Pricing of $8,000,000 Million Public Offering
11/12/2025
LA JOLLA, CA, Dec. 11, 2025 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an innovative pipeline of Natural Killer T (“NKT”) cell modulators for the [...]
NeXtGen™ Biologics Secures Favorable Outcome in Inter-Partes Patent Review
11/12/2025
GAINESVILLE, Fla., Dec. 11, 2025 (GLOBE NEWSWIRE) -- NeXtGen Biologics is pleased to report that the USPTO declined to initiate Inter Partes Review (“IPR”), following the filing by RegenX Science of two IPR Petitions in [...]
Acentra Health Names Patty Obermaier as Chief Growth Officer
11/12/2025
Proven healthcare leader to drive growth and product innovation in support of the company’s mission to accelerate better health outcomes MCLEAN, Va., Dec. 11, 2025 (GLOBE NEWSWIRE) -- Acentra Health , a technology and [...]
PetMed Express Comments on Unsolicited and Non-Binding Acquisition Proposal Received From SilverCape Investments Limited
11/12/2025
No Stockholder Action Required at this Time DELRAY BEACH, Fla., Dec. 11, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc., d/b/a PetMeds and parent company of PetCareRx, (Nasdaq: PETS) (the “Company” or “PetMeds”), today [...]
Eclipse Energy Announces Collaborative Partnership with Weatherford Accelerating Commercialization of Subsurface Clean Energy Technologies
11/12/2025
HOUSTON, Dec. 11, 2025 (GLOBE NEWSWIRE) -- Eclipse Energy today announced a collaborative partnership with Weatherford International plc (NASDAQ: WFRD) that includes a capital investment from Weatherford to accelerate [...]
Graham and Courtney Rahal Foundation Donates $225,000 to SoldierStrong Through Vino for Vets Event
11/12/2025
NAPA VALLEY, Calif., Dec. 11, 2025 (GLOBE NEWSWIRE) -- The Graham & Courtney Rahal Foundation (GCRF) hosted its fourth-annual Vino For Vets powered by DropLight fundraiser in October, donating $225,000 to benefit [...]
Parsley Health Launches BYO Labs Review: The First Clinician-Led Service Turning Outside Lab Data Into Personalized Health Plans
11/12/2025
New York, New York, Dec. 11, 2025 (GLOBE NEWSWIRE) -- Parsley Health , the nationally recognized functional medicine platform known for combining advanced diagnostics with root-cause medical care, today announced the [...]
MD Logic Health & Well Minerals Launch Pure Whole Food Vitamin C, a Premium, 100% Natural Vitamin C Supplement Sourced Exclusively from Organic Fruit
11/12/2025
Miami, FL, Dec. 11, 2025 (GLOBE NEWSWIRE) -- In an era where consumers are increasingly conscious of the origins and quality of their nutritional supplements, Well Minerals x MD Logic Health® 's new collaboration [...]
Certara Appoints Jon Resnick as Chief Executive Officer
11/12/2025
Resnick brings decades of leadership experience in health sciences, business operations, strategy, innovation and commercial growth William Feehery to step down as CEO on December 31, 2025 Company reaffirms full year [...]
InnoCare Announces Approval of the Next-Generation TRK Inhibitor Zurletrectinib in China
11/12/2025
BEIJING, Dec. 11, 2025 (GLOBE NEWSWIRE) -- InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company, announced today that its next-generation TRK inhibitor, zurletrectinib (ICP-723), has received [...]
AtaiBeckley Announces New U.S. Patent Granted for EMP-01, Strengthening Intellectual Property Portfolio
11/12/2025
NEW YORK and AMSTERDAM, Dec. 11, 2025 (GLOBE NEWSWIRE) -- Atai Beckley N.V. (NASDAQ: ATAI) (“AtaiBeckley” or the “Company”), a clinical-stage biopharmaceutical company on a mission to transform patient outcomes by [...]

Pages